Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0038 | 0 | 0.5 |
Chlamydia trachomatis | 6-phosphogluconolactonase | 0.013 | 1 | 0.5 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0038 | 0 | 0.5 |
Schistosoma mansoni | 6-phosphogluconolactonase | 0.013 | 1 | 1 |
Mycobacterium tuberculosis | Probable 6-phosphogluconolactonase DevB (6PGL) | 0.0092 | 0.5903 | 0.5 |
Trypanosoma cruzi | 6-phosphogluconolactonase, putative | 0.013 | 1 | 1 |
Entamoeba histolytica | glucosamine-6-phosphate isomerase, putative | 0.0038 | 0 | 0.5 |
Echinococcus granulosus | 6 phosphogluconolactonase | 0.013 | 1 | 0.5 |
Loa Loa (eye worm) | 6-phosphogluconolactonase | 0.013 | 1 | 0.5 |
Plasmodium vivax | glucose-6-phosphate 1-dehydrogenase, putative | 0.0038 | 0 | 0.5 |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.0038 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphogluconolactonase, putative | 0.013 | 1 | 1 |
Giardia lamblia | Glucose-6-phosphate 1-dehydrogenase | 0.0038 | 0 | 0.5 |
Mycobacterium leprae | Probable 6-phosphogluconolactonase DevB (6PGL) | 0.013 | 1 | 0.5 |
Mycobacterium ulcerans | 6-phosphogluconolactonase | 0.013 | 1 | 0.5 |
Giardia lamblia | Glucosamine-6-phosphate deaminase | 0.0038 | 0 | 0.5 |
Leishmania major | 6-phosphogluconolactonase | 0.013 | 1 | 1 |
Treponema pallidum | glucose-6-phosphate 1-dehydrogenase | 0.013 | 1 | 0.5 |
Trypanosoma brucei | 6-phosphogluconolactonase | 0.013 | 1 | 1 |
Giardia lamblia | Glucosamine-6-phosphate deaminase | 0.0038 | 0 | 0.5 |
Schistosoma mansoni | 6-phosphogluconolactonase | 0.013 | 1 | 1 |
Plasmodium falciparum | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0.0038 | 0 | 0.5 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0038 | 0 | 0.5 |
Trichomonas vaginalis | 6-phosphogluconolactonase, putative | 0.0038 | 0 | 0.5 |
Echinococcus multilocularis | 6 phosphogluconolactonase | 0.013 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.